Key result
Chronic hyperglycemia and lipotoxicity activate RAGE, TLR4, NF-κB, and NLRP3 inflammasome signaling, driving myocardial pyroptosis, fibrosis, and dysfunction in diabetes.
Why the study?
Although cardiac inflammation links metabolic stress to myocardial injury and remodeling in diabetes mellitus, the temporal and causal relationships among these processes, particularly potential feedback from myocardial injury to metabolic stress, remain incompletely established.
Answers are grounded in this paper and cite their sources.
This narrative review proposes a conceptual metabolic–immune–myocardial injury cycle linking hyperglycemia and lipotoxicity to innate immune activation and myocardial remodeling, highlighting potential therapeutic targets to slow diabetic cardiomyopathy progression.
Diabetes mellitus is a major metabolic disorder associated with progressive cardiovascular complications, including diabetic cardiomyopathy. Increasing evidence indicates that cardiac inflammation links metabolic stress to myocardial injury and structural remodeling. However, the temporal and causal relationships among these processes, particularly the potential feedback from myocardial injury to metabolic stress, remain incompletely established. Objective: This review synthesizes current evidence on the mechanisms underlying cardiac inflammation in diabetes and proposes an integrated framework linking metabolic, immune, and myocardial respones. Methods: A structured narrative review was conducted with reference to the principles of the Scale for the Assessment of Narrative Review Articles (SANRA). Literature published from January 2020 to July 2026 was identified through PubMed, Scopus, Web of Science, and ScienceDirect using combinations of MeSH and free-text terms related to diabetes, diabetic cardiomyopathy, inflammation, oxidative stress, mitochondrial dysfunction, NLRP3 inflamasome, and pyroptosis. Results: Chronic hyperglycemia and lipotoxicity promote advanced glycation end products, oxidative stress, and mitochondrial dysfunction, which activate RAGE, TLR4, NF-κB, and NLRP3 inflamasome signaling. These pathways promote inflammatory communication among macrophages, cardiomyocytes, and fibroblasts, contributing to pyroptosis, hypertrophy, fibrosis, and myocardial dysfunction. Persistent tissue injury may further amplify local inflammation through damage-associated molecular patterns and mitochondrial danger signals. However, evidence supporting a complete closed positive feedback loop, particularly a causal pathway from myocardial injury back to the initiating metabolic stress, remains limited. Conclusion: The metabolic–immune–myocardial injury cycle is proposed as a conceptual hypothesis to explain the persistence and potential amplification of cardiac inflammation in diabetes. Targeting this interconnected network may provide opportunities for preventing or slowing diabetic cardiomyopathy progression.
No takes yet. Share an insight, caveat, or question.
Fitri et al. (2026) conducted a review in Diabetes mellitus and diabetic cardiomyopathy. Chronic hyperglycemia and lipotoxicity activate RAGE, TLR4, NF-κB, and NLRP3 inflammasome signaling, driving myocardial pyroptosis, fibrosis, and dysfunction in diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: